Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)

CAPS Rating: 5 out of 5

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories.

Recs

3
Player Avatar angel696i (< 20) Submitted: 7/21/2009 6:04:15 AM : Underperform Start Price: $45.21 TEVA Score: +85.58

TEVA is a "defensive" stock. not something that will boost your portfolio when the market goes bull.
people think its Generics, but 30% from TEVA's income is from ethics products - copaxone (for MS) and expose to generics competition. no biogenerics (FOB) in USA means no way to grow in the next 5 years after copaxone loses its patent.

Report this Post 2 Replies
Member Avatar Mega (99.97) Submitted: 4/9/2012 6:41:22 PM
Recs: 0

"TEVA is a "defensive" stock. not something that will boost your portfolio when the market goes bull."

Maybe you should take a quick glance at the 10 year chart.

Member Avatar ikkyu2 (99.32) Submitted: 3/27/2013 5:39:44 PM
Recs: 0

Copaxone is not exposed to generics competition; the FDA has ruled that its competitors must conduct their own clinical trials.

Featured Broker Partners


Advertisement